Enable job alerts via email!
A next-gen pharmatech company is seeking a Manager to lead the Molecular Simulations team in London. This role involves optimizing physics-based computational methods to support drug discovery programs. Candidates should possess a PhD in a relevant field and have substantial experience in computational drug discovery and team leadership. The position offers a dynamic environment focused on innovative drug candidates and includes some remote work options.
This job is brought to you by Jobs/Redefined, the UK's leading over-50s age inclusive jobs board.
About AQEMIA
AQEMIA is a next-gen pharmatech company generating one of the world's fastest-growing drug discovery pipelines. Our mission is to design fast innovative drug candidates for dozens of critical diseases, such as immuno-oncology. Our unique approach leverages quantum-inspired physics algorithms to power generative AI in designing novel drug candidates without relying on experimental data. We have delivered several drug discovery successes within our internal pipeline and through collaborations with pharmaceutical companies. Our most advanced programs are currently in vivo optimization.
About Aqemia
Aqemia is a pioneering TechBio company leveraging physics-based computational methods and machine learning to scale drug discovery. Our Molecular Simulations Team plays a crucial role in maximising the impact of physics-based computational methods in our drug discovery programs.
We are looking for a Manager to lead our Molecular Simulations team, which plays a key role in advancing our drug discovery programs. The team focuses on applying and optimising physics-based computational methods to support hit discovery and lead optimisation, helping to accelerate the development of novel drug candidates. The ideal candidate combines strong leadership skills to guide a team of scientists with deep expertise in statistical mechanics and computational chemistry.
At AQEMIA, we work for a mission: joining us means having your own impact on changing the way drugs are discovered, and helping to shape the direction of our fast-growing company and team.
Expanding Drug Discovery Pipeline: Focused on critical therapeutic areas like Oncology, CNS, Immuno-inflammation... with in vivo proof of concept/patent stage programs. Collaborations with top Pharma, including a $140M Sanofi deal.
Interdisciplinary Team: brilliant talent from tech and life sciences.
DeepTech Recognition: Part of French Tech 120 and France 2030.
Prime Location: Based in central Paris and London (King\'s Cross) with the possibility of 2 remote days per week.
International Environment: The work language is English - relocation support and French lessons granted if needed.
Strong Financial Backing: $100M raised from leading European and International investors